{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:35:58Z","timestamp":1787664958871,"version":"build-2736575974"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Medical Science Research Project of Hebei","award":["20221353"],"award-info":[{"award-number":["20221353"]}]},{"name":"S&T Program of Hebei","award":["22377769D"],"award-info":[{"award-number":["22377769D"]}]},{"DOI":"10.13039\/501100003787","name":"Hebei Natural Science Foundation","doi-asserted-by":"crossref","award":["H2022206391"],"award-info":[{"award-number":["H2022206391"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-025-05427-4","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:50:05Z","timestamp":1762505405000},"page":"825-840","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["AURKA modulates tight junction functionality to influence the proliferation and metastasis of lung adenocarcinoma"],"prefix":"10.1007","volume":"481","author":[{"given":"Yuan","family":"Mi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruibo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lantao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"5427_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"5427_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cells13211785","author":"DD Ghosh","year":"2024","unstructured":"Ghosh DD, Mcdonald H, Dutta R, Krishnan K, Thilakan J, Paul MK, Arya N, Rao M, Rangnekar VM (2024) Prognostic indicators for precision treatment of non-small cell lung carcinoma. Cells. https:\/\/doi.org\/10.3390\/cells13211785","journal-title":"Cells"},{"key":"5427_CR3","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41571-021-00501-4","volume":"18","author":"JE Chaft","year":"2021","unstructured":"Chaft JE, Rimner A, Weder W, Azzoli CG, Kris MG, Cascone T (2021) Evolution of systemic therapy for stages I-III non-metastatic non-small-cell lung cancer. Nat Rev Clin Oncol 18:547\u2013557","journal-title":"Nat Rev Clin Oncol"},{"key":"5427_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286\u2013287","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA (2024) Cancer treatments: past, present, and future. Cancer Genet 286\u2013287:18\u201324","journal-title":"Cancer Genet"},{"key":"5427_CR5","doi-asserted-by":"publisher","first-page":"5040","DOI":"10.1158\/1078-0432.CCR-09-0520","volume":"15","author":"L Horn","year":"2009","unstructured":"Horn L, Sandler A (2009) Epidermal growth factor receptor inhibitors and antiangiogenic agents for the treatment of non-small cell lung cancer. Clin Cancer Res 15:5040\u20135048","journal-title":"Clin Cancer Res"},{"key":"5427_CR6","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1200\/JCO.20.01605","volume":"39","author":"H Borghaei","year":"2021","unstructured":"Borghaei H, Gettinger S, Vokes EE, Chow LQM, Burgio MA, De Castro Carpeno J, Pluzanski A, Arrieta O, Frontera OA, Chiari R, Butts C, W\u00f3JCIK-TOMASZEWSKA J, Coudert B, Garassino MC, Ready N, Felip E, GARC\u00edA MA, Waterhouse D, Domine M, Barlesi F, Antonia S, Wohlleber M, Gerber DE, Czyzewicz G, Spigel DR, Crino L, Eberhardt WEE, Li A, Marimuthu S, Brahmer J (2021) Five-year outcomes from the randomized, phase III trials CheckMate 017 and 057: nivolumab versus docetaxel in previously treated non-small-cell lung cancer. J Clin Oncol 39:723\u2013733","journal-title":"J Clin Oncol"},{"key":"5427_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.canlet.2021.03.028","volume":"509","author":"J Wang","year":"2021","unstructured":"Wang J, Hu T, Wang Q, Chen R, Xie Y, Chang H, Cheng J (2021) Repression of the AURKA-CXCL5 axis induces autophagic cell death and promotes radiosensitivity in non-small-cell lung cancer. Cancer Lett 509:89\u2013104","journal-title":"Cancer Lett"},{"key":"5427_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2021.119016","volume":"1868","author":"CY Wang","year":"2021","unstructured":"Wang CY, Lee MH, Kao YR, Hsiao SH, Hong SY, Wu CW (2021) Alisertib inhibits migration and invasion of EGFR-TKI resistant cells by partially reversing the epithelial-mesenchymal transition. Biochimica et Biophysica Acta (BBA) 1868:119016","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"5427_CR9","doi-asserted-by":"publisher","first-page":"T47","DOI":"10.1530\/ERC-17-0072","volume":"24","author":"A Ogden","year":"2017","unstructured":"Ogden A, Rida PCG, Aneja R (2017) Centrosome amplification: a suspect in breast cancer and racial disparities. Endocr Relat Cancer 24:T47-t64","journal-title":"Endocr Relat Cancer"},{"key":"5427_CR10","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.leukres.2010.07.034","volume":"35","author":"AR Lucena-Araujo","year":"2011","unstructured":"Lucena-Araujo AR, De Oliveira FM, Leite-Cueva SD, Dos Santos GA, Falcao RP, Rego EM (2011) High expression of AURKA and AURKB is associated with unfavorable cytogenetic abnormalities and high white blood cell count in patients with acute myeloid leukemia. Leuk Res 35:260\u2013264","journal-title":"Leuk Res"},{"key":"5427_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18210-3","volume":"7","author":"K Kivinummi","year":"2017","unstructured":"Kivinummi K, Urbanucci A, Leinonen K, Tammela TLJ, Annala M, Isaacs WB, Bova GS, Nykter M, Visakorpi T (2017) The expression of AURKA is androgen regulated in castration-resistant prostate cancer. Sci Rep 7:17978","journal-title":"Sci Rep"},{"key":"5427_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41591-018-0264-7","volume":"25","author":"KN Shah","year":"2019","unstructured":"Shah KN, Bhatt R, Rotow J, Rohrberg J, Olivas V, Wang VE, Hemmati G, Martins MM, Maynard A, Kuhn J, Galeas J, Donnella HJ, Kaushik S, Ku A, Dumont S, Krings G, Haringsma HJ, Robillard L, Simmons AD, Harding TC, Mccormick F, Goga A, Blakely CM, Bivona TG, Bandyopadhyay S (2019) Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer. Nat Med 25:111\u2013118","journal-title":"Nat Med"},{"key":"5427_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41419-024-06577-x","volume":"15","author":"B Deng","year":"2024","unstructured":"Deng B, Liu F, Chen N, Li X, Lei J, Chen N, Wu J, Wang X, Lu J, Fang M, Chen A, Zhang Z, He B, Yan M, Zhang Y, Wang Z, Liu Q (2024) AURKA emerges as a vulnerable target for KEAP1-deficient non-small cell lung cancer by activation of asparagine synthesis. Cell Death Dis 15:233","journal-title":"Cell Death Dis"},{"key":"5427_CR14","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fonc.2015.00278","volume":"5","author":"V Bavetsias","year":"2015","unstructured":"Bavetsias V, Linardopoulos S (2015) Aurora kinase inhibitors: current status and outlook. Front Oncol 5:278","journal-title":"Front Oncol"},{"key":"5427_CR15","doi-asserted-by":"publisher","first-page":"6229","DOI":"10.18632\/oncotarget.2190","volume":"5","author":"IA Asteriti","year":"2014","unstructured":"Asteriti IA, Di Cesare E, De Mattia F, Hilsenstein V, Neumann B, Cundari E, Lavia P, Guarguaglini G (2014) The Aurora-A inhibitor MLN8237 affects multiple mitotic processes and induces dose-dependent mitotic abnormalities and aneuploidy. Oncotarget 5:6229\u20136242","journal-title":"Oncotarget"},{"key":"5427_CR16","first-page":"425","volume":"9","author":"YH Ding","year":"2015","unstructured":"Ding YH, Zhou ZW, Ha CF, Zhang XY, Pan ST, He ZX, Edelman JL, Wang D, Yang YX, Zhang X, Duan W, Yang T, Qiu JX, Zhou SF (2015) Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells. Drug Des Devel Ther 9:425\u2013464","journal-title":"Drug Des Devel Ther"},{"key":"5427_CR17","first-page":"1555","volume":"9","author":"NK Niu","year":"2015","unstructured":"Niu NK, Wang ZL, Pan ST, Ding HQ, Au GH, He ZX, Zhou ZW, Xiao G, Yang YX, Zhang X, Yang T, Chen XW, Qiu JX, Zhou SF (2015) Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK\/PI3K\/Akt\/mTOR signaling pathway. Drug Des Devel Ther 9:1555\u20131584","journal-title":"Drug Des Devel Ther"},{"key":"5427_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17010041","author":"BJ Ren","year":"2015","unstructured":"Ren BJ, Zhou ZW, Zhu DJ, Ju YL, Wu JH, Ouyang MZ, Chen XW, Zhou SF (2015) Alisertib induces cell cycle arrest, apoptosis, autophagy and suppresses EMT in HT29 and Caco-2 cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms17010041","journal-title":"Int J Mol Sci"},{"key":"5427_CR19","first-page":"575","volume":"9","author":"F Wang","year":"2015","unstructured":"Wang F, Li H, Yan XG, Zhou ZW, Yi ZG, He ZX, Pan ST, Yang YX, Wang ZZ, Zhang X, Yang T, Qiu JX, Zhou SF (2015) Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K\/Akt\/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells. Drug Des Devel Ther 9:575\u2013601","journal-title":"Drug Des Devel Ther"},{"key":"5427_CR20","doi-asserted-by":"publisher","first-page":"50290","DOI":"10.18632\/oncotarget.10366","volume":"7","author":"TM Pitts","year":"2016","unstructured":"Pitts TM, Bradshaw-Pierce EL, Bagby SM, Hyatt SL, Selby HM, Spreafico A, Tentler JJ, McPhillips K, Klauck PJ, Capasso A, Diamond JR, Davis SL, Tan AC, Arcaroli JJ, Purkey A, Messersmith WA, Ecsedy JA, Eckhardt SG (2016) Antitumor activity of the aurora A selective kinase inhibitor, alisertib, against preclinical models of colorectal cancer. Oncotarget 7:50290\u201350301","journal-title":"Oncotarget"},{"key":"5427_CR21","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.3390\/cells13161397","volume":"13","author":"P Federica","year":"2024","unstructured":"Federica P, Anna M, Giulia G (2024) Contribution of AurkA\/TPX2 overexpression to chromosomal imbalances and cancer. Cells 13:1397","journal-title":"Cells"},{"key":"5427_CR22","doi-asserted-by":"publisher","first-page":"2282184","DOI":"10.1080\/07853890.2023.2282184","volume":"56","author":"C Menghua","year":"2024","unstructured":"Menghua C, Huijun Z, Jian L, Danjing L, Jiaming Z, Wenqi L, Jue W (2024) Research progress on the relationship between AURKA and tumorigenesis: the neglected nuclear function of AURKA. Ann Med 56:2282184","journal-title":"Ann Med"},{"key":"5427_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06485-0","volume":"15","author":"H Chen","year":"2024","unstructured":"Chen H, Hu J, Xiong X, Chen H, Lin B, Chen Y, Li Y, Cheng D, Li Z (2024) AURKA inhibition induces Ewing\u2019s sarcoma apoptosis and ferroptosis through NPM1\/YAP1 axis. Cell Death Dis 15:99","journal-title":"Cell Death Dis"},{"key":"5427_CR24","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41419-021-03894-3","volume":"12","author":"M Li","year":"2021","unstructured":"Li M, Sun C, Bu X, Que Y, Zhang L, Zhang Y, Zhang L, Lu S, Huang J, Zhu J, Wang J, Sun F, Zhang Y (2021) ISL1 promoted tumorigenesis and EMT via Aurora kinase A-induced activation of PI3K\/AKT signaling pathway in neuroblastoma. Cell Death Dis 12:620","journal-title":"Cell Death Dis"},{"key":"5427_CR25","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.1038\/s41388-020-1369-2","volume":"39","author":"D Ruijuan","year":"2020","unstructured":"Ruijuan D, Chuntian H, Hanyong C, Kangdong L, Pu X, Ning Y, Lu Y, Liting Z, Qiong W, Yaqiu Z, Mingxia X, Zigang D, Xiang L (2020) SDCBP\/MDA-9\/syntenin phosphorylation by AURKA promotes esophageal squamous cell carcinoma progression through the EGFR-PI3K-Akt signaling pathway. Oncogene 39:5405\u20135419","journal-title":"Oncogene"},{"key":"5427_CR26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI161929","author":"W Xiaobo","year":"2023","unstructured":"Xiaobo W, Jing H, Fenglin L, Qian Y, Ruina W, Jiaqi W, Zewen Z, Juan Y, Jun H, Joong Sup S, Wei J, Zengxia L, Yuanyuan Z, Yongjun D (2023) Aurora A kinase inhibition compromises its antitumor efficacy by elevating PD-L1 expression. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI161929","journal-title":"J Clin Invest"},{"key":"5427_CR27","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1158\/1535-7163.MCT-18-0529","volume":"18","author":"J Du","year":"2019","unstructured":"Du J, Yan L, Torres R, Gong X, Bian H, Marugan C, Boehnke K, Baquero C, Hui Y, Chapman S, Yang Y, Zeng Y, Bogner S, Foreman R, Capen A, Donoho G, van Horn R, Barnard D, Dempsey J, Beckmann R, Marshall M, Chio L, Qian Y, Webster Y, Aggarwal A, Chu S, Bhattachar S, Stancato L, Dowless M, Iversen P, Manro J, Walgren J, Halstead B, Dieter M, Martinez R, Bhagwat S, Kreklau E, Lallena M, Ye X, Patel B, Reinhard C, Plowman G, Barda D, Henry J, Buchanan S, Campbell R (2019) Aurora A-selective inhibitor LY3295668 leads to dominant mitotic arrest, apoptosis in cancer cells, and shows potent preclinical antitumor efficacy. Mol Cancer Ther 18:2207\u20132219","journal-title":"Mol Cancer Ther"},{"key":"5427_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.bbrc.2018.10.170","volume":"507","author":"H Dawei","year":"2018","unstructured":"Dawei H, Honggang D, Qian W (2018) AURKA contributes to the progression of oral squamous cell carcinoma (OSCC) through modulating epithelial-to-mesenchymal transition (EMT) and apoptosis via the regulation of ROS. Biochem Biophys Res Commun 507:83\u201390","journal-title":"Biochem Biophys Res Commun"},{"key":"5427_CR29","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.3390\/biom12101378","volume":"12","author":"X Qian-Rui","year":"2022","unstructured":"Qian-Rui X, Xiao-Hui D, Ting-Ting H, Yu-Chun Z, Yu-Ling L, Dan-Yi H, Hao-Qiang D, En-Min L, Wang-Kai F (2022) Role of cell-cell junctions in oesophageal squamous cell carcinoma. Biomolecules 12:1378","journal-title":"Biomolecules"},{"key":"5427_CR30","doi-asserted-by":"crossref","unstructured":"Daisuke K, Akira T, Shin K, Ichiro T, Makoto O, Takashi K (2020) Role of tight junctions in the epithelial-to-mesenchymal transition of cancer cells. Biochim Biophys Acta Biomembr 1863:183503","DOI":"10.1016\/j.bbamem.2020.183503"},{"key":"5427_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/cells12020243","volume":"12","author":"N Zeina","year":"2023","unstructured":"Zeina N, Natascha R, Punita D, Thomas FB (2023) Tight junction protein signaling and cancer biology. Cells 12:243","journal-title":"Cells"},{"key":"5427_CR32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2002","unstructured":"Livak KJ, Schmittgen TD (2002) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402\u2013408","journal-title":"Methods"},{"key":"5427_CR33","first-page":"210","volume":"12","author":"H Yuzhen","year":"2020","unstructured":"Yuzhen H, Ganzhu F (2020) MiR-423\u20135p aggravates lung adenocarcinoma via targeting CADM1. Thorac Cancer 12:210\u2013217","journal-title":"Thorac Cancer"},{"key":"5427_CR34","first-page":"1627","volume":"9","author":"J Li","year":"2015","unstructured":"Li J, Yang Y, Liu Q, Pan S, He Z, Zhang X, Yang T, Chen X, Wang D, Qiu J, Zhou S (2015) The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2\/M arrest, apoptosis, and autophagy via p38 MAPK and Akt\/mTOR signaling pathways in human breast cancer cells. Drug Des Devel Ther 9:1627\u20131652","journal-title":"Drug Des Devel Ther"},{"key":"5427_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-61779-108-6_8","volume":"740","author":"M Zimmermann","year":"2011","unstructured":"Zimmermann M, Meyer N (2011) Annexin V\/7-AAD staining in keratinocytes. Methods Mol Biol (Clifton, NJ) 740:57\u201363","journal-title":"Methods Mol Biol (Clifton, NJ)"},{"key":"5427_CR36","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1186\/s13019-024-03075-1","volume":"19","author":"Y Shen","year":"2024","unstructured":"Shen Y, Han R, Yu X, Mao J (2024) Hsa_circ_0079929 in lung adenocarcinoma and its biological implications in lung adenocarcinoma progression. J Cardiothorac Surg 19:549","journal-title":"J Cardiothorac Surg"},{"key":"5427_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cells10112869","author":"M Bandela","year":"2021","unstructured":"Bandela M, Letsiou E, Natarajan V, Ware L, Garcia J, Singla S, Dudek S (2021) Cortactin modulates lung endothelial apoptosis induced by cigarette smoke. Cells. https:\/\/doi.org\/10.3390\/cells10112869","journal-title":"Cells"},{"key":"5427_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2023.102048","volume":"82","author":"P Zhang","year":"2023","unstructured":"Zhang P, Sun Y, Shi L, Sun D, Wang L, Feng D, Ding C (2023) Effect of isorhamnetin on carbonic anhydrase IX expression and tumorigenesis of bladder cancer by activating PPAR\u03b3\/PTEN\/AKT pathway. Tissue Cell 82:102048","journal-title":"Tissue Cell"},{"key":"5427_CR39","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00726-021-03001-y","volume":"53","author":"H Tatsuya","year":"2021","unstructured":"Tatsuya H, Ami M, Yoshiko I, Hiroyuki K, Hitoshi M (2021) Cystine reduces tight junction permeability and intestinal inflammation induced by oxidative stress in Caco-2 cells. Amino Acids 53:1021\u20131032","journal-title":"Amino Acids"},{"key":"5427_CR40","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12964-022-00976-3","volume":"20","author":"X Yan","year":"2022","unstructured":"Yan X, Xueting W, Baolan W, Dongzhi W, Meiqi L, Kang C, Qianqian L, Dan W, Yapeng L, Li Z (2022) Caveolin-1 accelerates hypoxia-induced endothelial dysfunction in high-altitude cerebral edema. Cell Commun Signal 20:160","journal-title":"Cell Commun Signal"},{"key":"5427_CR41","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.jamcollsurg.2015.12.006","volume":"222","author":"L Wei","year":"2016","unstructured":"Wei L, Dong H, Haizhong H, Weifeng Z, Fatemeh A, Sarah M, Juan MR, Sarah SG, Sulaiman RH, Richard AH (2016) Intestinal alkaline phosphatase regulates tight junction protein levels. J Am Coll Surg 222:1009\u20131017","journal-title":"J Am Coll Surg"},{"key":"5427_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.153936","volume":"235","author":"J Peter","year":"2022","unstructured":"Peter J, David H, Thomas K, Frederick K, Jens N (2022) AURKA is a prognostic biomarker for good overall survival in stage II colorectal cancer patients. Pathol Res Pract 235:153936","journal-title":"Pathol Res Pract"},{"key":"5427_CR43","first-page":"050","volume":"13","author":"K Ketaki","year":"2021","unstructured":"Ketaki K, Suman G, Anup Kumar R (2021) A study of CD44 positive cancer cells in epithelial ovarian cancer and their correlation with P53 And Ki67. J Lab Phys 13:050\u2013057","journal-title":"J Lab Phys"},{"key":"5427_CR44","doi-asserted-by":"publisher","first-page":"289","DOI":"10.21147\/j.issn.1000-9604.2025.02.12","volume":"37","author":"H Liu","year":"2025","unstructured":"Liu H, Dilger JP (2025) Different strategies for cancer treatment: targeting cancer cells or their neighbors? Chin J Cancer Res 37:289\u2013292","journal-title":"Chin J Cancer Res"},{"key":"5427_CR45","doi-asserted-by":"publisher","first-page":"1201573","DOI":"10.3389\/fimmu.2023.1201573","volume":"14","author":"R Qianhe","year":"2023","unstructured":"Qianhe R, Pengpeng Z, Haoran L, Yanlong F, Hao C, Xiao Z, Zhijia X, Huabao C, Yue Y (2023) A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts. Front Immunol 14:1201573","journal-title":"Front Immunol"},{"key":"5427_CR46","volume":"247","author":"R Muhammad","year":"2022","unstructured":"Muhammad R, Simon K, Fien M, Sarah-Lee B, Ellen S, Aline E, Fanny DV, Joshua Robert G, Martijn R, Jan M, Bram DW, Serge VC, Kaat D (2022) Targeted AURKA degradation: towards new therapeutic agents for neuroblastoma. Eur J Med Chem 247:115033","journal-title":"Eur J Med Chem"},{"key":"5427_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2022.152314","volume":"228","author":"J Danxian","year":"2023","unstructured":"Danxian J, Huikuan C, Jinxin C, Yonghua C, Jing H, Yijie W (2023) AURKA, as a potential prognostic biomarker, regulates autophagy and immune infiltration in nasopharyngeal carcinoma. Immunobiology 228:152314","journal-title":"Immunobiology"},{"key":"5427_CR48","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s12032-022-01777-x","volume":"39","author":"W Fuping","year":"2022","unstructured":"Fuping W, Haotian Z, Haitao W, Tian Q, Binghong H, Qiong Y (2022) Combination of AURKA inhibitor and HSP90 inhibitor to treat breast cancer with AURKA overexpression and TP53 mutations. Med Oncol 39:180","journal-title":"Med Oncol"},{"key":"5427_CR49","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/cdd.2014.137","volume":"22","author":"L Galluzzi","year":"2015","unstructured":"Galluzzi L, Bravo-San Pedro J, Vitale I, Aaronson S, Abrams J, Adam D, Alnemri E, Altucci L, Andrews D, Annicchiarico-Petruzzelli M, Baehrecke E, Bazan N, Bertrand M, Bianchi K, Blagosklonny M, Blomgren K, Borner C, Bredesen D, Brenner C, Campanella M, Candi E, Cecconi F, Chan F, Chandel N, Cheng E, Chipuk J, Cidlowski J, Ciechanover A, Dawson T, Dawson V, De Laurenzi V, De Maria R, Debatin K, Di Daniele N, Dixit V, Dynlacht B, El-Deiry W, Fimia G, Flavell R, Fulda S, Garrido C, Gougeon M, Green D, Gronemeyer H, Hajnoczky G, Hardwick J, Hengartner M, Ichijo H, Joseph B, Jost P, Kaufmann T, Kepp O, Klionsky D, Knight R, Kumar S, Lemasters J, Levine B, Linkermann A, Lipton S, Lockshin R, L\u00f3PEZ-OT\u00edN C, Lugli E, Madeo F, Malorni W, Marine J, Martin S, Martinou J, Medema J, Meier P, Melino S, Mizushima N, Moll U, MU\u00f1OZ-PINEDO C, NU\u00f1EZ G, Oberst A, Panaretakis T, Penninger J, Peter M, Piacentini M, Pinton P, Prehn J, Puthalakath H, Rabinovich G, Ravichandran K, Rizzuto R, Rodrigues C, Rubinsztein D, Rudel T, Shi Y, Simon H, Stockwell B, Szabadkai G, Tait S, Tang H, Tavernarakis N, Tsujimoto Y, Vanden Berghe T, Vandenabeele P, Villunger A, Wagner E et al (2015) Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ 22:58\u201373","journal-title":"Cell Death Differ"},{"key":"5427_CR50","volume":"821","author":"H Ma","year":"2020","unstructured":"Ma H, Poon R (2020) Aurora kinases and DNA damage response. Mutat Res Fundam Mol Mech Mutagen 821:111716","journal-title":"Mutat Res Fundam Mol Mech Mutagen"},{"key":"5427_CR51","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s13018-020-01681-y","volume":"15","author":"Y Liu","year":"2020","unstructured":"Liu Y, Xi Y, Chen G, Wu X, He M (2020) URG4 mediates cell proliferation and cell cycle in osteosarcoma via GSK3\u03b2\/\u03b2-catenin\/cyclin D1 signaling pathway. J Orthop Surg Res 15:226","journal-title":"J Orthop Surg Res"},{"key":"5427_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e23833","volume":"10","author":"S Wang","year":"2024","unstructured":"Wang S, Zhang Y, Yang X, Wang K, Yang X, Zhang B, Zhang B, Bie Q (2024) Betulinic acid arrests cell cycle at G2\/M phase by up-regulating metallothionein 1G inhibiting proliferation of colon cancer cells. Heliyon 10:e23833","journal-title":"Heliyon"},{"key":"5427_CR53","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12943-021-01312-y","volume":"20","author":"M Li","year":"2021","unstructured":"Li M, Liu L, Dong M (2021) Progress on pivotal role and application of exosome in lung cancer carcinogenesis, diagnosis, therapy and prognosis. Mol Cancer 20:22","journal-title":"Mol Cancer"},{"key":"5427_CR54","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41419-022-04642-x","volume":"13","author":"Z Bao","year":"2022","unstructured":"Bao Z, Li A, Lu X, Wang Z, Yu Y, Wu W, Zhao L, Li B, Wu X, Laster K, Zhang C, Jiang Y, Dong Z, Liu K (2022) Oxethazaine inhibits esophageal squamous cell carcinoma proliferation and metastasis by targeting aurora kinase A. Cell Death Dis 13:189","journal-title":"Cell Death Dis"},{"key":"5427_CR55","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1038\/s41598-017-02623-1","volume":"7","author":"X Jiang-Long","year":"2017","unstructured":"Jiang-Long X, Wen-Jun F, Fei-Meng Z, Wen-Wen Z, Jia-Jun X, Meng-Ying Y, Muhammad K, Peng W, Hong-Ming T, Chun-Li W, Quentin L (2017) Inhibition of AURKA kinase activity suppresses collective invasion in a microfluidic cell culture platform. Sci Rep 7:2973","journal-title":"Sci Rep"},{"key":"5427_CR56","doi-asserted-by":"publisher","first-page":"393","DOI":"10.21873\/invivo.11486","volume":"33","author":"Z Lianhua","year":"2019","unstructured":"Lianhua Z, Eunae C, Guohua Z, Mi Ryung R, Zhenlong Z (2019) The pathogenic effect of cortactin tyrosine phosphorylation in cutaneous squamous cell carcinoma. In Vivo 33:393\u2013400","journal-title":"In Vivo"},{"key":"5427_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085796","volume":"9","author":"MR Vijayababu","year":"2014","unstructured":"Vijayababu MR, Pawel K, Gavin Y, Rajalakshmy R, Bhumasamudram J, Eugene AM, Jesse DM, Fayez KG, Pawel RK (2014) pTyr421 cortactin is overexpressed in colon cancer and is dephosphorylated by curcumin: involvement of non-receptor type 1 protein tyrosine phosphatase (PTPN1). PLoS ONE 9:e85796","journal-title":"PLoS ONE"},{"key":"5427_CR58","doi-asserted-by":"crossref","unstructured":"Bangbin C, Renge B, Xuewen X (2020) Expression of tight junction proteins is altered in bladder cancer. Anal Cell Pathol (Amst) 2020","DOI":"10.1155\/2020\/6341256"},{"key":"5427_CR59","first-page":"2887","volume":"6","author":"N Songshi","year":"2013","unstructured":"Songshi N, Liqin X, Jianfei H, Jian F, Huijun Z, Gui W, Xudong W (2013) Increased ZO-1 expression predicts valuable prognosis in non-small cell lung cancer. Int J Clin Exp Pathol 6:2887","journal-title":"Int J Clin Exp Pathol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05427-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-025-05427-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05427-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T11:12:59Z","timestamp":1772709179000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-025-05427-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":59,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["5427"],"URL":"https:\/\/doi.org\/10.1007\/s11010-025-05427-4","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"1 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Ethics Committee of the Fourth Hospital of Hebei Medical University (Shijiazhuang, China) approved the human study. All clinical samples in this study were collected from the specimen bank of the Fourth Hospital of Hebei Medical University. The animal study complied with the Guide for the Care and Use of Laboratory Animals (8th Edition, NIH) and experiments were approved by the Laboratory Animal Care and Use Committee of the Fourth Hospital of Hebei Medical University (Shijiazhuang, China).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The study involving the usage of clinical samples was approved by the Ethics Committee of the Fourth Hospital of Hebei Medical University and was performed in accordance with the Declaration of Helsinki. Informed consent was obtained from all subjects and\/or their legal guardian(s). The study was reported in accordance with ARRIVE guidelines.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}